Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection

被引:0
|
作者
Slavcev, A
Lácha, J
Honsová, E
Sajdlová, H
Lodererová, A
Vitko, S
Skibová, J
Striz, I
机构
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:S70 / S70
页数:1
相关论文
共 50 条
  • [1] Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection
    Slavcev, A
    Lácha, J
    Honsová, E
    Sajdlová, H
    Lodererová, A
    Vitko, S
    Skibová, J
    Striz, I
    TRANSPLANT IMMUNOLOGY, 2005, 14 (02) : 117 - 121
  • [2] HLA antibodies and soluble CD30 in lung transplant recipients
    Kauper, Barbara
    Lavingia, Bhavna
    Rogers, James
    Nottingham, Kelly
    Ring, W. Sieves
    Rosenblatt, Randall L.
    Torres, Fernando
    Meyer, Dan M.
    Stastny, Peter
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S62 - S62
  • [3] SOLUBLE CD30 FOR THE PREDICTION AND DETECTION OF KIDNEY TRANSPLANT REJECTION
    Arjona, Alvaro
    DRUG NEWS & PERSPECTIVES, 2009, 22 (07) : 409 - 413
  • [4] Prediction of acute kidney alllograft rejection by analysis of HLA antibodies, soluble CD30 and hepatocyte growth factor
    Pavlova, Yelena A.
    Slavcev, Antonij
    Buergelova, Marcela
    Susal, Caner
    Slatinska, Janka
    Opelz, Gerhard
    Skibova, Jelena
    Sajdlova, Helena
    Kolesar, Libor
    Viklicky, Ondrej
    TISSUE ANTIGENS, 2010, 75 (05): : 596 - 597
  • [5] Soluble CD30 and HLA antibodies have an independent and additive effect on post transplant kidney graft outcome
    Langan, Leanne L.
    Hughes, Tiffany L.
    Park, Larry P.
    Luxton, Grant
    Witt, Campbell S.
    Irish, Ashley B.
    Christiansen, Frank T.
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S37 - S37
  • [6] Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant
    Domingues, Elizabeth M. F. L.
    Matuck, Teresa
    Graciano, Miguel L.
    Souza, Edison
    Rioja, Suzimar
    Falci, Monica C.
    Monteiro de Carvalho, Deise B.
    Porto, Luis Cristovao
    CLINICAL TRANSPLANTATION, 2010, 24 (06) : 821 - 829
  • [7] Soluble CD30 as a possible risk factor for acute rejection after kidney transplantation
    Slavcev, A
    Lacha, J
    Sajdlova, H
    Valhova, S
    Vitko, S
    Striz, I
    GENES AND IMMUNITY, 2004, 5 : S15 - S15
  • [8] SOLUBLE HLA-G AS AN INDICATOR FOR GRAFT REJECTION IN KIDNEY AND KIDNEY/PANCREAS TRANSPLANTATION SUPERIOR TO SOLUBLE CD30 LEVELS
    Rebmann, V.
    Moellenbeck, P.
    Bartsch, D.
    Heinemann, F. M.
    Wunsch, A.
    Golda, T.
    Viebahn, R.
    Horn, P. A.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 42 - 42
  • [9] The role of soluble CD30 (SCD30) as a predictive biomarker for increased risk of acute rejection (AR) in kidney transplant recipients
    El-Khatib, M.
    Sergeant, R.
    Brookes, P.
    TISSUE ANTIGENS, 2011, 77 (05): : 442 - 442
  • [10] Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation
    Grenzi, Patricia C.
    Campos, Erika F.
    Silva, Helio T., Jr.
    Felipe, Claudia R.
    Franco, Marcelo F.
    Soares, Maria F.
    Medina-Pestana, Jose O.
    Gerbase-DeLima, Maria
    TRANSPLANT IMMUNOLOGY, 2015, 32 (02) : 61 - 65